Snowball logo
logo
BIOS_logo

BioSenic S.A.

BIOS BR
0.0020.00  (0%)
Estimate
EPS
-0.02
Beta
-1.602
About the company
Ticker
BIOS
ISIN
BE0974280126
Country
Belgium
Sector (GICS)
Healthcare
BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.

Frequently asked questions

What sector does BioSenic S.A. (BIOS) operate in?

BioSenic S.A. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is BioSenic S.A. (BIOS) current stock price?

As of the latest data, BioSenic S.A. stock price is €0.00, with a previous close of €0.00.

What is BioSenic S.A. (BIOS) current market capitalization?

BioSenic S.A. market cap is approximately 1.31 million.

What is BioSenic S.A. (BIOS) Earnings Per Share (EPS)?

The trailing EPS is -€0.02.

Does BioSenic S.A. (BIOS) pay dividends?

No. BioSenic S.A. does not pay a dividend.

What is BioSenic S.A. (BIOS) beta (volatility) score?

BioSenic S.A. has a beta of -1.602, indicating lower volatility than the overall market.